The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia

Bin Hu,1,* Jie Zheng,2,* Qing Liu,1 Yunkuan Yang,1 Ying Zhang2 1Department of Pain Management, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China; 2Department of Anesthesiology, the Affiliated Traditional Chines...

Full description

Bibliographic Details
Main Authors: Hu B, Zheng J, Liu Q, Yang Y, Zhang Y
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Journal of Pain Research
Subjects:
Online Access:https://www.dovepress.com/the-effect-and-safety-of-ozone-autohemotherapy-combined-with-pharmacol-peer-reviewed-article-JPR
id doaj-art-50a6290a6a354c4fb0054ac63bc2e6de
recordtype oai_dc
spelling doaj-art-50a6290a6a354c4fb0054ac63bc2e6de2018-08-29T20:33:56ZengDove Medical PressJournal of Pain Research1178-70902018-08-01Volume 111637164340085The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgiaHu BZheng JLiu QYang YZhang YBin Hu,1,* Jie Zheng,2,* Qing Liu,1 Yunkuan Yang,1 Ying Zhang2 1Department of Pain Management, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China; 2Department of Anesthesiology, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China *These authors contributed equally to this work Introduction: We investigated the effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia (PHN).Methods: Ninety-eight patients with PHN were enrolled in this study and randomly divided into a pharmacological therapy group and ozone autohemotherapy group (49 patients in each group). The PHN patients in the pharmacological therapy group were administered pharmacological therapy for 2 weeks, whereas PHN patients in the ozone autohemotherapy group were given ozone autohemotherapy (200 mL blood from patients, the concentration of medical ozone was set as 30 μg/mL using an ozone medical apparatus, 40 mL medical ozone was incubated in 200 mL autologous blood for 3–5 minutes) combined with pharmacological therapy for 2 weeks. The Visual Analog Scale (VAS), the 50% VAS reduction in the initial value, McGill Pain Questionnaire (MPQ), the Patients’ Global Impression of Change (PGIC) scale, and the World Health Organization Quality of Life (WHOQOL-BREF) instrument were used to evaluate the outcomes of all PHN patients before therapy and at 1 week, 1 month, and 3 months after therapy.Results: Forty-five patients in the pharmacological therapy group and 47 patients in the ozone autohemotherapy group completed the study. Compared with before therapy, the two groups showed significant improvements in VAS, MPQ, PGIC, and WHOQOL-BREF scores after therapy (P<0.05). Moreover, compared with the scores of the pharmacological therapy group, the ozone autohemotherapy group’s scores were significantly improved in the VAS, MPQ, PGIC, and WHOQOL-BREF as well as the 50% VAS reduction of the initial value after therapy (P<0.05). Finally, there were no statistically significant differences in adverse effects between groups after therapy (P>0.05).Conclusion: The results of this study demonstrated that ozone autohemotherapy combined with pharmacological therapy was superior to isolated pharmacological therapy in patients with PHN and was an effective and safe way to relieve PHN. Keywords: ozone autohemotherapy, pharmacological therapy, clinical trial, postherpetic neuralgiahttps://www.dovepress.com/the-effect-and-safety-of-ozone-autohemotherapy-combined-with-pharmacol-peer-reviewed-article-JPROzone autohemotherapyPharmacological therapyClinical trialPostherpetic neuralgia
institution Open Data Bank
collection Open Access Journals
building Directory of Open Access Journals
language English
format Article
author Hu B
Zheng J
Liu Q
Yang Y
Zhang Y
spellingShingle Hu B
Zheng J
Liu Q
Yang Y
Zhang Y
The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
Journal of Pain Research
Ozone autohemotherapy
Pharmacological therapy
Clinical trial
Postherpetic neuralgia
author_facet Hu B
Zheng J
Liu Q
Yang Y
Zhang Y
author_sort Hu B
title The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
title_short The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
title_full The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
title_fullStr The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
title_full_unstemmed The effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
title_sort effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia
publisher Dove Medical Press
series Journal of Pain Research
issn 1178-7090
publishDate 2018-08-01
description Bin Hu,1,* Jie Zheng,2,* Qing Liu,1 Yunkuan Yang,1 Ying Zhang2 1Department of Pain Management, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China; 2Department of Anesthesiology, the Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, People’s Republic of China *These authors contributed equally to this work Introduction: We investigated the effect and safety of ozone autohemotherapy combined with pharmacological therapy in postherpetic neuralgia (PHN).Methods: Ninety-eight patients with PHN were enrolled in this study and randomly divided into a pharmacological therapy group and ozone autohemotherapy group (49 patients in each group). The PHN patients in the pharmacological therapy group were administered pharmacological therapy for 2 weeks, whereas PHN patients in the ozone autohemotherapy group were given ozone autohemotherapy (200 mL blood from patients, the concentration of medical ozone was set as 30 μg/mL using an ozone medical apparatus, 40 mL medical ozone was incubated in 200 mL autologous blood for 3–5 minutes) combined with pharmacological therapy for 2 weeks. The Visual Analog Scale (VAS), the 50% VAS reduction in the initial value, McGill Pain Questionnaire (MPQ), the Patients’ Global Impression of Change (PGIC) scale, and the World Health Organization Quality of Life (WHOQOL-BREF) instrument were used to evaluate the outcomes of all PHN patients before therapy and at 1 week, 1 month, and 3 months after therapy.Results: Forty-five patients in the pharmacological therapy group and 47 patients in the ozone autohemotherapy group completed the study. Compared with before therapy, the two groups showed significant improvements in VAS, MPQ, PGIC, and WHOQOL-BREF scores after therapy (P<0.05). Moreover, compared with the scores of the pharmacological therapy group, the ozone autohemotherapy group’s scores were significantly improved in the VAS, MPQ, PGIC, and WHOQOL-BREF as well as the 50% VAS reduction of the initial value after therapy (P<0.05). Finally, there were no statistically significant differences in adverse effects between groups after therapy (P>0.05).Conclusion: The results of this study demonstrated that ozone autohemotherapy combined with pharmacological therapy was superior to isolated pharmacological therapy in patients with PHN and was an effective and safe way to relieve PHN. Keywords: ozone autohemotherapy, pharmacological therapy, clinical trial, postherpetic neuralgia
topic Ozone autohemotherapy
Pharmacological therapy
Clinical trial
Postherpetic neuralgia
url https://www.dovepress.com/the-effect-and-safety-of-ozone-autohemotherapy-combined-with-pharmacol-peer-reviewed-article-JPR
_version_ 1612665893751357440